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Abstract: 
We evaluated biochemical endpoints related to oxidative stress in brains of neonatal rats exposed to manganese 
(Mn). Oral Mn chloride (MnCl2) (0, 25, or 50 mg Mn chloride kg
-1
 body weight per day) was given daily to 
neonatal rats throughout lactation (i.e. from postnatal day (PND) 1 to 21). As previously reported by [J. Appl. 
Toxicol. 20 (2000) 179], this treatment paradigm results in increased cerebral cortex (CTY) Mn concentrations 
in PND 21 rats from both Mn treatment groups. High dose Mn exposure also results in increased cerebellar Mn 
concentrations. This preliminary study determined whether this exposure paradigm also affects cerebrocortical 
or cerebellar metallothionein (MT) mRNA levels, glutamine synthetase (GS) activity, GS protein levels, as well 
as total glutathione (GSH) levels. High dose Mn exposure significantly increased (P < 0.05) total 
cerebrocortical GSH without accompanying changes in any of the other measured parameters. Therefore, it is 
unlikely that high dose Mn exposure is associated with oxidative stress in this experimental paradigm. 
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Article: 
INTRODUCTION 
Manganese (Mn) encephalopathy is characterized by high levels of Mn in the globus pallidus and neuronal loss 
in the basal ganglia and associated nuclei of the extrapyramidal system (Barbeau, 1984; Nelson et al., 1993; 
Schochet and Nelson, 1991). Neonatal rats appear to be at an increased risk for Mn-induced neurotoxicity due 
to their ability to accumulate higher brain Mn levels and develop more pronounced brain pathology than do 
adults in the face of equivalent or lesser Mn exposures (Chandra and Shukla, 1978; Dorman et al., 2000; Seth et 
al., 1977; Shukla et al., 1980). Dorman et al. (2000) demonstrated reduced weight gain, increased pulse-elicited 
acoustic startle response amplitude, and increased striatal dopamine and 3,4-dihydroxyphenylacetic acid levels 
in neonates given high (50 mg MnCl2 kg
-1
 body weight per day) oral doses of Mn. Factors influencing this 
increased susceptibility include increased Mn absorption from the gastrointestinal tract (Kostial et al., 1978; 
Rehnberg et al., 1982), an incompletely formed blood-brain barrier and the virtual absence of biliary Mn 
excretory mechanisms until weaning (Miller et al., 1975). 
 
One proposed mechanism for Mn-induced neurotoxicity is a cascade of oxidative damage potentiated by the 
synergism of excess Mn and high concentrations of iron and dopamine in affected brain regions (Aschner, 
1997). The brain, in general, is highly susceptible to oxidative damage because it has a high rate of oxidative 
metabolism, high concentrations of polyunsaturated fatty acids and low to moderate levels of antioxidant 
enzymes. There is some evidence that the developing rat brain may be more sensitive to oxidative stress. For 
example, Driver et al. (2000) demonstrated that brain homogenates prepared from neonatal rats incubated in the 
presence of divalent iron formed higher amounts of reactive oxygen species (ROS) than similarly treated brain 
homogenates collected from adult rats. 
 
It has been theorized that elevated concentrations of Mn might significantly accelerate the oxidation of 
dopamine and other catecholamines and concurrently amplify the formation of ROS (Sloot et al., 1996). 
Donaldson et al. (1980) presented in vitro evidence that divalent Mn increases dopamine autoxidation and thus 
may induce oxidative damage. It has been demonstrated that divalent Mn (Mn
2+
) catalyzes Fenton-like reactions 
that generate hydroxyl radical and trigger proteolytic degradation and protein turnover (Wedler, 1993). Ali et al. 
(1995) demonstrated dose-related increases in ROS production in rat caudate nucleus after in vivo Mn exposure. 
Tyree and Archibald (1987) have postulated that trivalent Mn is the neurotoxication of concern. Whether 
originally entering in the +2, +3, or +4 oxidation state, Mn will, via spontaneous oxidation and dismutation, 
peroxidative activity, or oxygen radical-mediated oxidation, give rise to Mn
3+
 which in a simple complex, 
perhaps with catecholamines themselves, will oxidatively destroy dopamine, epinephrine, norepinephrine, and 
their precursor DOPA in an efficient manner (Archibald and Tyree, 1987). 
 
The goal of the present study was to determine whether pre-weaning Mn exposure is associated with 
biochemical changes that might be indicative of oxidative stress in the developing rat brain. The rat is not 
ideally suited for studies on Mn neurotoxicity, since Mn is ubiquitously distributed in this species, whilst 
preferentially localized in basal ganglia of primates (Aschner et al., 2001). Nevertheless, since a series of 
biochemical measurements was conducted in cerebral cortex (CTX) and cerebellar cortex (CB) derived from the 
animal cohorts previously described by Dorman et al. (2000), we had a unique opportunity to broaden the 
database on Mn neurotoxicity in this animal model. It should also be noted, that studies in areas most germane 
to primate Mn-induced neurotoxicity (basal ganglia) could not be performed on this animal cohort, since these 
areas were unavailable for analyses due to the shortage of tissues. Metallothionein (MT; a protein scavenger of 
metals) mRNA levels, glutamine synthetase (GS; a key component of glutamate and ammonia detoxification) 
activity and protein levels, as well as total glutathione (GSH) levels were determined as indicators of oxidative 
stress (Section 4). 
 
MATERIALS AND METHODS  
Animal Treatment 
Primiparous pregnant CD rats (gestational day 13-15) were purchased from Charles River Laboratories 
(Raleigh, NC). The animals were housed in polycarbonate cages containing cellulose-fiber chip bedding 
(ALPHA-dri
TM
; Shepard Specialty Papers, Kalama-zoo, MI) which were located in a HEPA-filtered, mass air-
displacement room maintained at 20 ± 1 °C and 50 ± 10% relative humidity with a 12-h (07:00/19:00) light—
dark cycle. The study was approved by the CIIT Institutional Animal Care and Use Committee (IACUC) and 
conducted under federal guidelines for the care and use of laboratory animals. 
 
Mn dichloride tetrahydrate (MnCl2
.
4H2O) was obtained from Sigma Chemical Co. (St. Louis, MO). Mn was 
dissolved in nanopure water and given to the neonates by mouth using a micropipette for 21 consecutive days at 
doses of 0, 25 or 50 mg MnCl2 kg
-1
 body weight. The date of parturition was designated as postnatal day 0 
(PND 0). On PND 4, litters were randomly reduced to four animals per sex whenever possible. Litters of less 
than eight pups were not used. Pups were dosed according to the average pup weight for each litter starting on 
the day after birth (PND 1) until weaning (PND 21). Clinical examinations (Dorman et al., 2000) were 
performed daily on all the animals before Mn administration. The neonatal rats were killed on PND 21 (with 
CO2), and samples of cerebellum and CTX were collected and frozen in liquid nitrogen. 
 
RNA Isolation and Northern Blot Analysis 
The RNA tissue samples were homogenized and total RNA was extracted with a monophase phenol and 
guanidine isothiocyanate solution (RNA STAT-60, Tel-Test Inc., Friendswood, TX). For Northern analysis, 10 
μg of RNA were electrophoresed on a 1.2% agarose denaturing gel and transferred onto a positively charged 
nylon membrane (Nytran SuPerCharge, Schleicher & Schuell, Keene, NH) overnight by capillary transfer in 10 
x SSC (1 x SSC = 0.15 M sodium chloride, 0.015 M sodium citrate) buffer. The RNA was immobilized with a 
UV crosslinker. 
 
For MT, the blot was prehybridized in 50% deionized formamide, 5x Denhardt's solution, 10% dextran sulfate, 
0.1% sodium dodecyl sulfate (SDS), 4x SSC 100 g/ml denatured salmon sperm DNA, 20 mM Tris pH 8.0 for 1 
h at 45 'C. To probe for MT, the blot was prehybridized in ultrasensitive hybridization buffer (Ambion Inc., 
Austin, TX) at 45 °C. The RNA blots were then hybridized overnight with 10
5
 cpm/ml of [alpha-
32
P] dCTP-
labeled random primed cDNA probe (approximately 1 X 10
8
 cpm/μg; RadPrime DNA Labeling System, 
GibcoBRL, Life Technologies, Rockville, MD). Membranes were washed 2-3 times in 2 x SSC/0.1% SDS at 45 
°C for 20 min and then exposed to Kodak Biomax MR film, at —80°C with intensifying screens for 24-36 h. 
The autoradiograms were quantified by densitometry scanning in conjunction with the TINA v2.09e computer 
program (Raytest USA INC., Wilmington, NC). To correct for total loaded RNA level, the blots were stripped 
in 0.1 x SSC/0.1%SDS/40 mM Tris buffer and probed for 28s rRNA (Barbu and Dautry, 1989). 
 
Protein Isolation and Western Blot Analysis 
Tissue lysates were centrifuged for 10 min at 10,000 x g to remove cellular debris and the protein content of the 
resultant supernatant was determined with the bicinchoninic acid method (Pierce Chemical, Rockford, IL). An 
aliquot of 100 μg of protein was concentrated from the imidazole lysis buffer by organic extraction. Sample 
volumes were brought up to 400 μl with water and an equal volume of methanol (400 μl) was added, followed 
by 100 μl of chloroform. Samples were vortexed for 20 s and centrifuged at 14,000 x g for 3 min. The upper 
layer was removed and discarded. An additional 300 μl of methanol was added to each sample and they were 
again vortexed and centrifuged. The supernatant was removed and the pellet was air dried. Each pellet was then 
dissolved in 100 μl 2% SDS and heated to 65 °C. 
 
Five microliter of 5 x loading buffer (50% glycerol; 10% SDS, 0.25 M Tris pH 6.8) and DTT (final 
concentration 100 mM) were added to the extracted proteins and the samples were boiled for 10 min. 
Bromophenol blue (1 μl of a 50% w/v solution) was added and proteins were resolved by denaturing SDS-
PAGE with a 5% stacking and 8% resolving acrylamide gels in a 0.1% SDS, 25 mM Tris, 192 mM glycine 
buffer. Following fractionation, proteins were electrophorectically transferred to a nitrocellulose membrane 
(Protran, BA83, Schleicher & Schuell, Keene, NH) in 20% methanol, 0.1% SDS, 25 mM Tris and 192 mM 
glycine for 3 h at 60 V. 
 
Membranes were blocked with 5% low-fat powdered milk in Tris-buffered saline with Tween (TBST, 0.1% 
Tween, 150 mM NaCl, 20 mM Tris) containing 0.1% gelatin (type B from bovine skin, Sigma, St. Louis, MO). 
GS proteins were detected with a monoclonal antibody (Chemicon, Temecula, CA) diluted to 1:2000 followed 
by incubation with a horseradish peroxidase conjugated secondary antibody diluted to 1:2000 (Kirkegaard and 
Perry Laboratories, Gaithersburg, MD), both in TBST and 5% milk for 1 h. Protein bands were visualized with 
the Renaissance enhanced chemiluminescence system (New England Nuclear, Boston, MA). The 
autoradiograms were quantified by densitometry scanning in conjunction with the TINA v2.09e computer 
program (Raytest USA Inc., Wilmington, NC). 
 
Glutamine Synthetase Activity 
An aliquot of the tissue lysate (150 μg) was added to a fresh microcentrifuge tube and the volume was brought 
up to 400 μl with lysis buffer. A 2x reaction buffer was prepared fresh to provide a final assay concentration of 
120 mM L-glutamine, 10 mM sodium arsenate, 50 mM imidazole and 30 mM hydroxylamine, pH 6.5. 
Immediately prior to use, MnCl2 (30 μM final concentration) and ATP (200 μM final concentration) were added 
to the 2x reaction buffer. The 2 x reaction buffer (400 μl) was added to the 400 μl of tissue lysate. The 
microcentrifuge tubes were gently vortexed and incubated at 37 °C for 60 min. Standards of L-glutamic acid γ-
monohydroxamate (γ-glutamyl hydroxamate) were prepared in imidazole lysis buffer and incubated in parallel 
with the experi-mental samples. Following incubation, 200 μl of FeCl3 buffer (FeCl3
.
7H2O 15% w/v 
trichloroacetic acid 25% v/v, hydrochloric acid 2.5 N) was added and proteins were allowed to precipitate for 
60 min at 4 °C, after which time the samples were centrifuged for 10 min at 10,000 x g. The absorbance of the 
supernatant was measured at 490 nm with a molecular devices Vmax kinetic microplate reader (Sunnyvale, CA). 
 
GSH Level Determination 
Tissue samples (50-100 mg) were homogenized in 1 ml of 10% (v/v) percholoric acid containing 1 mM 
bathophenanthroline disulfonic (BPDS) acid and L-γ-glutamyl-L-glutamate. The mixture was vortexed and 
centrifuged and an aliquot was removed for HPLC analysis (Fariss and Reed, 1987) with a Waters model 600E 
multisolvent delivery system using an ion-exchange method with a methanol—acetate mobile phase and 
gradient elution. The limit of GSH detection was approximately 50 pmol, which equated to approximately 0.4 
nmol/mg protein (Lash and Tokarz, 1990; Lash and Woods, 1991). 
Statistical Analysis 
All experiments were conducted using five to seven treated neonates per Mn treatment group. To determine 
statistical significance, one-way analysis of variance (ANOVA) was used and when the overall significance 
resulted in rejection of the null hypothesis (P < 0.05), the source of the variance was determined with the 
Student—Newman—Keuls post-test. All analyses were performed using GraphPad InStat version 3.02 for 
Windows (GraphPad Software, San Diego, CA). Unless otherwise noted, all data presented represent mean ± 
S.E.M. values. 
 
RESULTS 
GS Protein Expression and Activity 
Mn treatment did not significantly alter either GS protein expression or the levels of GS enzyme activity in 
either the CTX or the CB (Table 1). 
 
 
GSH Levels 
Mn treatment of neonatal rats did not significantly alter the levels of total GSH in the CB (Table 2). However, a 
statistically significant increase (P < 0.05) in total GSH levels was noted in the CTX of pups treated with the 
high Mn dose when compared to control rats (Table 2). 
 
 
 
MT mRNA Levels 
Northern blot analyses revealed that treatment of neonatal rats with either the low or high Mn dose did not alter 
the levels of MT mRNA in either the CTX or the CB (Table 3). 
 
DISCUSSION 
The exposure to Mn in our experiments is approximately 75-150-fold higher than from consumption of rat's 
milk (Keen et al., 1981) and will result in an approximately two-fold increase in brain Mn concentrations in 
weanling animals (Dorman et al., 2000). As reported by Dorman et al. (2000), weanling rats given either 25 or 
50 mg kg
-1
 body weight per day MnCl2 from PND 1 to 21 had significantly increased cortical Mn 
concentrations when compared with control animals given water. Increased cerebellar Mn levels were also 
observed in neonates exposed to the high Mn dose (50 mg MnCl2 kg
-1
 body weight per day). 
 
Mn has been shown to enhance the autoxidation and/ or turnover of intracellular catecholamines, resulting in 
increased production of ROS and other cytotoxic metabolites, concomitant with depletion of antioxidant 
defense mechanisms (Donaldson, 1987; Graham, 1984; Liccione and Maines, 1988; Parenti et al., 1988). 
Injection of Mn produced changes in monoamine concentrations in different brain regions of rats dosed with 
either MnCl2 (Mn
+2
) or MnOAc (Mn
+3
) (Parenti et al., 1988). ROS were measured by a molecular probe, 2',7'- 
dichlorofluorescein diacetate (DCFH-DA), and both divalent and trivalent Mn led to ROS generation; how-
ever, Mn
+3
 was shown to be an order of magnitude more potent than Mn
+2
 (Ali et al., 1995). Consistent with 
Mn-induced oxidative stress, Desole et al. (1995) reported that allopurinol antagonized Mn-induced oxidative 
stress by inhibiting dopamine-induced oxidative stress in the brainstem of 3-month-old male rats dosed with Mn 
(MnCl2). The same authors (Desole et al., 1994) have also established that the response of striatal cellular 
defense mechanisms (e.g. increase in ascorbic acid (AA) oxidation, decrease in GSH levels) highly correlated 
with changes in markers of dopaminergic system activity and uric acid levels, providing evidence for Mn-
induced oxidative stress via xanthine oxidase. 
 
Brenneman et al. (1999) failed to demonstrate elevated striatal 8-hydroxy-2'-deoxyguanosine (8-OHdG) 
concentrations in young rats orally exposed to 0, 25, or 50 mg kg
-1
 per day of MnCl2 from PND 1 to 49 despite 
observing elevated Mn levels in mitochondria isolated from the striatum. Their findings suggest that even 
relatively high dose oral Mn exposure does not significantly alter 8-OHdG levels in either mitochondrial or 
nuclear DNA. A failure to observe increased 8-OHdG levels following Mn exposure does not eliminate ROS 
formation in the pathogenesis of Mn-induced neurotoxicity. As suggested by Halliwell (2000) 8-OHdG may be 
only a minor product of oxidative DNA damage. Indeed, 8-OHdG may be difficult to measure because of the 
ease with which it is formed artifactually during isolation, hydrolysis and analysis of DNA. Accordingly, direct 
measures of mRNA, protein expression and activity of proteins that are known to be "markers" for oxidative 
stress (such as GS; Levine et al., 1981; Liaw et al., 1993; Nakamura and Stadtman, 1984) and redox status 
(total, reduced and oxidized GSH; MT) are likely to provide more meaningful assessment of oxidative stress. 
 
Brenneman et al. (1999) reported Mn-induced elevations in ROS levels in the PND 49 rat cerebellum, but not 
striatum. In the present study we only observed an absolute increase in the total amount of GSH in the cortex of 
PND 21 rats given Mn throughout lactation. The dose of Mn used resulted in significantly increased cerebellar 
and cortical Mn levels in neonates exposed to the high Mn dose (50 mg MnCl2 kg
-1
 body weight per day) 
(Dorman et al., 2000). The tripeptide GSH (γ-glutamylcysteinylglycine) is the major anti-oxidant in mammalian 
cells constituting nearly 90% of the intracellular non-protein thiols (Anderson and Meister, 1983). It is 
important in maintaining the intracellular redox status of protein thiols, for protection against endogenous and 
exogenous sources of oxidative stress, and for the conjugation and excretion of toxic molecules (Meister, 1988, 
1991; Stohs and Bagchi, 1995). It is unclear at this point whether this modest increase in GSH reflects oxidative 
stress, but given that we failed to note a significant change in levels of oxidized GSH in the cortex (data not 
shown), these preliminary data do not substantiate a pro-oxidant effect by Mn. 
 
Within the CNS, GS is localized almost exclusively in astrocytes (Martinez-Hernandez et al., 1977). Glutamine 
produced by astrocytes via the action of GS is released from astrocytes and taken up by neighboring 
glutamatergic or GABAergic neurons as precursors for neurotransmitter synthesis as part of the glutamate— 
glutamine cycle (Benjamin and Quasstel, 1975; Schousboe et al., 1992; Sonnewald et al., 1997). In addition to 
providing glutamine to neurons, other glutamate-derived metabolites, such as the tricarboxylic acid (TCA) cycle 
precursors lactate, malate and citrate are utilized by neurons for energy production (Sonnewald et al., 1991). 
Thus, inhibition of GS activity may result in decreased neuronal energy levels, decreased synthesis of glutamate 
and GABA, and the inability to detoxify ammonia within the CNS. Decreases in GS activity might be mediated 
by multiple mechanisms. The GS macromolecule is susceptible to oxidative modification resulting in decreased 
synthetic activity (Levine et al., 1981; Liaw et al., 1993; Nakamura and Stadtman, 1984). In addition to direct 
inactivation by ROS, the oxidized GS protein under-goes rapid degradation by intracellular proteases leading to 
decreases in both activity and protein levels. The present study failed to establish a statistically significant effect 
of Mn on GS protein levels and GS activity in cortex or cerebellum at either low or high dose. Given the 
exquisite susceptibility of GS to oxidative modification, the absence of decreased synthetic activity upon Mn 
exposure likely reflects on the absence of Mn-induced oxidative stress. 
 
The MTs, a class of cysteine-containing intracellular proteins, are characterized by a molecular mass of 
6-7 kDa. These highly conserved proteins are expressed in all mammals with a wide organ and cellular 
distribution and they represent an important metal binding protein (Andrews, 1990; Dunn et al., 1987; Hamer, 
1986). MT's antioxidant properties may depend on its metal speciation, namely, the ability of oxygen free 
radicals to release zinc from MT thiolate clusters (Hainaut and Milner, 1993). Circumstantial evidence supports 
the hypothesis that increased levels of MTs could potentially neutralize ROS in peripheral tissues and the CNS. 
Data in support of the antioxidant function of MT, derived from in situ hybridization studies, reveal that 
bacterial endotoxin induces MT gene expression in the brain (Itano et al., 1991). Transcriptional induction of 
the MT-I gene in the CNS is also increased by oxidative stress, kainic acid and 6-hydroxydopamine, which 
generates free radicals and is known to be toxic to dopaminergic neurons (Shiraga et al., 1993). Hypoxia 
produces a long lasting protection against kainic acid-induced injury, such that when kainic acid is injected into 
the CNS one week later, both seizures and neurodegenerative changes in the hippocampus and pyriform cortex 
are markedly reduced (Dalton et al., 1995). Collectively, these studies suggest a singularly important role for 
constitutive levels of MT as an antioxidant. In the present study we noted increased MT mRNA production in 
the cerebellum from PND 21 rats in the high Mn dose group; however, this increase was statistically 
insignificant, possibly due to the high variability in the blots and a definitive answer to this issue will have to 
await further studies. 
 
In summary, the present study determined whether oxidative stress plays a role in Mn-induced neurotoxicity in 
preweanling rats. Our preliminary results indicate a modest, yet significant change in the level of total GSH in 
rats exposed to high Mn dose versus controls. The change was limited to the cortex and it was absent from the 
cerebellum. The other measures of oxidative stress (MT mRNA; GS activity and protein levels) were 
unperturbed in both regions (cerebellum or cortex) and dose regimens (high and low Mn) compared with 
control rats. Given that the cortex does not represent a target area for Mn toxicity in primates, it cannot be 
unequivocally stated at this point that our data support the ability of Mn to induce oxidative stress in neonatal 
rats. Studies in our laboratory are presently being carried out to address this issue, focusing on Mn-induced 
oxidative stress in basal ganglia, representing preferential sites for Mn accumulation and toxicity in humans. 
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